Kolexia
Merino Diane
Psychiatrie
CHU Nice
Nice, France
39 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Effets secondaires indésirables des médicaments COVID-19 Migraines Amnésie globale transitoire Amnésie Hypersensibilité Glomérulonéphrite extra-membraneuse Catatonie Défaillance cardiaque

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Cardiac and metabolic safety profile of antipsychotics in youths: A WHO safety database analysis.
Psychiatry research   14 février 2024
An artificial intelligence algorithm for co-clustering to help in pharmacovigilance before and during the COVID-19 pandemic.
British journal of clinical pharmacology   08 février 2024
Pharmacogénétique des psychotropes : focus sur les recommandations actuelles
Edimark   31 décembre 2023
Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence.
Kidney international reports   03 novembre 2023
Drug-induced cardiac toxicity and adverse drug reactions, a narrative review.
Therapie   31 octobre 2023
Iatrogenic triggers for anorexia nervosa and bulimia nervosa: A WHO safety database disproportionality analysis.
Psychiatry research   16 août 2023
The Neuropsychiatric Safety Profile of Lasmiditan: A Comparative Disproportionality Analysis with Triptans.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics   12 juillet 2023
Drug-related catatonia in youths: real-world insights from the WHO Safety Database.
European child & adolescent psychiatry   12 juin 2023
Drug-induced minimal change disease: Disproportionality analysis of the WHO safety database
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Drug-induced membranous nephropathy: Disproportionality analysis of the WHO safety database
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023